Chemistry Wealth Management LLC grew its stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 52.5% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 15,517 shares of the company’s stock after purchasing an additional 5,339 shares during the period. Chemistry Wealth Management LLC’s holdings in Molina Healthcare were worth $3,549,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Torren Management LLC acquired a new stake in Molina Healthcare during the 4th quarter worth $26,000. Physician Wealth Advisors Inc. boosted its stake in Molina Healthcare by 1,250.0% in the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after acquiring an additional 200 shares in the last quarter. Quarry LP acquired a new position in Molina Healthcare in the fourth quarter valued at $32,000. SJS Investment Consulting Inc. grew its holdings in shares of Molina Healthcare by 504.9% during the first quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock worth $33,000 after purchasing an additional 207 shares during the last quarter. Finally, Elevation Wealth Partners LLC grew its holdings in shares of Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after purchasing an additional 78 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.
Molina Healthcare Price Performance
Shares of NYSE:MOH opened at $196.65 on Friday. The company has a 50-day simple moving average of $209.25 and a 200-day simple moving average of $177.81. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The stock has a market capitalization of $10.27 billion, a price-to-earnings ratio of -1,092.43, a PEG ratio of 28.14 and a beta of 0.75.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Mizuho set a $215.00 price target on Molina Healthcare in a research note on Monday, June 8th. Weiss Ratings lowered Molina Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, July 24th. Morgan Stanley boosted their price objective on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Finally, Robert W. Baird raised their target price on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $202.44.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by corporate insiders.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Recommended Stories
- Five stocks we like better than Molina Healthcare
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
